CoChat

Management of oral and gastrointestinal mucosal injury: ESMO Clinical Practice Guidelines for diagnosis, treatment, and follow-up

Open access

The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.

Abstract

Oral and gastrointestinal mucositis caused by high-dose chemotherapy and/or radiation continues to be an important clinical problem. Fortunately, there have been strategic advances over the past decade in understanding the molecular basis of the injury, providing opportunities for the development of drugs and devices to manage toxicity. The guidelines detailed below represent updates from the version published in the 2011 Annals of Oncology [1.Peterson D.E. Bensadoun R.J. Roila F. Management of oral and gastrointestinal mucositis: ESMO Clinical Practice Guidelines.Ann Oncol. 2011; 22: vi78-vi84Abstract Full Text Full Text PDF PubMed Scopus (183) Google Scholar], which were primarily based on the previous version of the guidelines produced by the Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society for Oral Oncology (MASCC/ISOO) [2.Keefe D.M. Schubert M.M. Elting L.S. et al.Updated clinical practice guidelines for the prevention and treatment of mucositis.Cancer. 2007; 109: 820-831Crossref PubMed Scopus (606) Google Scholar]. Three key advances have occurred in the four years following publication of the previous ESMO mucositis guidelines. Each of these advances (listed below) have been completed at the international, inter-professional level:•A comprehensive update of oral and gastrointestinal tract mucositis guidelines previously produced by the Mucositis Study Group of MASCC in 2007 [2.Keefe D.M. Schubert M.M. Elting L.S. et al.Updated clinical practice guidelines for the prevention and treatment of mucositis.Cancer. 2007; 109: 820-831Crossref PubMed Scopus (606) Google Scholar]. The most recent updated evidence-based guidelines, published in 2014 [3.Lalla R.V. Bowen J. Barasch A. et al.MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy.Cancer. 2014; 120: 1453-1461Crossref PubMed Scopus (714) Google Scholar], represent the state-of-the-science for mucositis management in patients receiving conventional chemotherapy and/or head and neck radiation.•Expert opinion on the management of mucosal injury caused by targeted cancer therapies such as vascular endothelial growth factor receptor (VEGFR) inhibitor, epidermal growth factor receptor (EGFR) inhibitors, (multi-targeted) tyrosine kinase inhibitors (TKIs), and mammalian target of rapamycin (mTOR) inhibitors [4.Boers-Doets C.B. Raber-Durlacher J.E. Treister N.S. et al.Mammalian target of rapamycin inhibitor-associated stomatitis.Future Oncol. 2013; 9: 1883-1892Crossref PubMed Scopus (59) Google Scholar]. Since oral complaints associated with mTOR inhibitors have been studied in detail, we are able to provide more in depth information about this specific side-effect. From other targeted treatments such as BRAF-, PARP-, CTLA4-, and MEK inhibitors there is no expert consensus available upon which to base recommendations or suggestions for treatment.•Novel approaches to enteral nutrition in patients receiving head and neck radiation [5.Nugent B. Lewis S. O'Sullivan J.M. Enteral feeding methods for nutritional management in patients with head and neck cancers being treated with radiotherapy and/or chemotherapy.Cochrane Database Syst Rev. 2013; 1: CD007904Crossref PubMed Scopus (64) Google Scholar, 6.Koyfman S.A. Adelstein D.J. Enteral feeding tubes in patients undergoing definitive chemoradiation therapy for head-and-neck cancer: a critical review.Intl J Radiat Oncol Biol Phys. 2012; 84: 581-589Abstract Full Text Full Text PDF PubMed Scopus (67) Google Scholar, 7.Williams G.F. Teo M.T. Sen M. et al.Enteral feeding outcomes after chemoradiotherapy for oropharynx cancer: a role for a prophylactic gastrostomy?.Oral Oncol. 2012; 48: 434-440Crossref PubMed Scopus (45) Google Scholar, 8.Rutter C.E. Yovino S. Taylor R. et al.Impact of early percutaneous endoscopic gastrostomy tube placement on nutritional status and hospitalization in patients with head and neck cancer receiving definitive chemoradiation therapy.Head Neck. 2011; 33: 1441-1447Crossref PubMed Scopus (62) Google Scholar, 9.Silander E. Nyman J. Bove M. et al.Impact of prophylactic percutaneous endoscopic gastrostomy on malnutrition and quality of life in patients with head and neck cancer: a randomized study.Head Neck. 2012; 34: 1-9Crossref PubMed Scopus (160) Google Scholar]. In France and French-speaking countries, the Société Francophone de Nutrition et Métabolisme (SFNEP) and the Association Francophone pour les Soins Oncologiques de Support (AFSOS) published comprehensive recommendations for cancer patients [10.SFNEP (Societe Francophone de Nutrition Enterale et Parenterale) SFNEP Oncology Nutrition Guidelines.Nutrition Clinique et Métabolisme. 2012; 26 (20 April 2015, date last accessed)http://www.em-consulte.com/revue/NUTCLI/26/4/table-des-matieres/Google Scholar, 11.Bachmann P. Romero G. Deneuve S. et al.Référentiel de pratiques professionnelles: prise en charge nutritionnelle des cancers des voies a

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/annonc/mdv202

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 3

  1. 2012, SFNEP (Societe Francophone de Nutrition Enterale et Parenterale) SFNEP Oncology Nutrition Guidelines, Nutrition Clinique et Métabolisme, 26
  2. Boers-Doets, 2013, The mIAS scale: a scale to measure mTOR inhibitor-associated stomatitis, Support Care Cancer, 21, S140
  3. Somerfield, 2000, ASCO clinical practice guidelines: process, progress, pitfalls, and prospects, Class Pap Curr Comments, 4, 881

Cited by

See all 334

Metadata

Authors
Peterson, D. E., Boers-Doets, C. B., Bensadoun, R. J., & Herrstedt, J.
Affiliations
  • UConn Health (US)
  • Leiden University Medical Center (NL)
  • Centre de Haute Energie (FR)
  • University of Southern Denmark (DK)
Venue
Annals of Oncology
Publisher
Elsevier BV
Published
2015-09
Volume
26
Pages
v139-v151
ISSN
0923-7534 (ISSN-L)
OpenAlex
W2149050045
Cited by
299
References
40
Citations by year
2026: 18 · 2025: 33 · 2024: 39 · 2023: 40 · 2022: 30 · 2021: 36 · 2020: 29 · 2019: 22 · 2018: 21 · 2017: 19 · 2016: 7 · 2015: 3
FWCI
13.17
Type
journal article
Language
en
Open access
Licence
Locations
  • Annals of Oncology (publishedVersion, other-oa)
  • PubMed (publishedVersion)
  • University of Southern Denmark Research Portal (University of Southern Denmark) (submittedVersion)
Topics
  • Health Sciences › Dentistry › General Dentistry › Oral health in cancer treatment
  • Health Sciences › Dentistry › General Dentistry › Oral Health Pathology and Treatment
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Chemotherapy-induced organ toxicity mitigation
Keywords
mucositis, oral mucositis, gastrointestinal mucositis, high-dose chemotherapy, radiotherapy-induced mucositis, mucositis prevention, mucositis treatment, cancer supportive care, head and neck cancer, ESMO guidelines
MeSH terms
Humans, Mouth Mucosa, Disease Management, Gastrointestinal Tract, Mucositis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.